Department of Pharmaceutical Technology, Jadavpur University, West Bengal, Kolkata 700032, India.
Department of Pharmaceutical Technology, Jadavpur University, West Bengal, Kolkata 700032, India.
Life Sci. 2021 May 15;273:119270. doi: 10.1016/j.lfs.2021.119270. Epub 2021 Feb 25.
Stem cells (SCs) are clonogenic cells that develop into the specialized cells which later responsible for making up various types of tissue in the human body. SCs are not only the appropriate source of information for cell division, molecular and cellular processes, and tissue homeostasis but also one of the major putative biological aids to diagnose and cure various degenerative diseases. This study emphasises on various research outputs that occurred in the past two decades. This will give brief information on classification, differentiation, detection, and various isolation techniques of SCs. Here, the various signalling pathways which includes WNT, Sonic hedgehog, Notch, BMI1 and C-met pathways and how does it effect on the regeneration of various classes of SCs and factors that regulates the potency of the SCs are also been discussed. We also focused on the application of SCs in the area of regenerative medicine along with the cellular markers that are useful as salient diagnostic or curative tools or in both, by the process of reprogramming, which includes diabetes, cancer, cardiovascular disorders and neurological disorders. The biomarkers that are mentioned in various literatures and experiments include PDX1, FOXA2, HNF6, and NKX6-1 (for diabetes); CD33, CD24, CD133 (for cancer); c-Kit, SCA-1, Wilm's tumor 1 (for cardiovascular disorders); and OCT4, SOX2, c-MYC, EN1, DAT and VMAT2 (for neurological disorders). In this review, we come to know the advancements and scopes of potential SC-based therapies, its diverse applications in clinical fields that can be helpful in the near future.
干细胞(SCs)是具有克隆能力的细胞,可分化为构成人体各种组织的特化细胞。SCs 不仅是细胞分裂、分子和细胞过程以及组织动态平衡的适当信息来源,也是诊断和治疗各种退行性疾病的主要潜在生物学辅助手段之一。本研究强调了过去二十年中发生的各种研究成果。本文将简要介绍 SCs 的分类、分化、检测和各种分离技术。这里讨论了各种信号通路,包括 WNT、Sonic hedgehog、Notch、BMI1 和 C-met 通路,以及它们如何影响各种类别的 SCs 的再生,以及调节 SCs 效力的因素。我们还专注于 SCs 在再生医学领域的应用,以及细胞标记物,这些标记物可作为有价值的诊断或治疗工具,或通过重编程过程,包括糖尿病、癌症、心血管疾病和神经疾病,在两者中都很有用。在各种文献和实验中提到的生物标志物包括 PDX1、FOXA2、HNF6 和 NKX6-1(用于糖尿病);CD33、CD24、CD133(用于癌症);c-Kit、SCA-1、Wilm's 肿瘤 1(用于心血管疾病);以及 OCT4、SOX2、c-MYC、EN1、DAT 和 VMAT2(用于神经疾病)。在这篇综述中,我们了解了基于 SC 的治疗方法的进展和范围,以及它们在临床领域的多样化应用,这些应用在不久的将来可能会有所帮助。